You are here: Industry Insights > GlobalData

News List

Less than five per cent of adults with overactive bladder currently treated with drug therapies: GlobalData ExpressPharma
January 06, 2022
Less than five per cent of adults across the eight major markets — the US, France, Germany, Italy, Spain, the UK, Japan, and China — with overactive bladder are currently managed with drug therapy...
Digital transformation will improve clinical trial process, say experts EuropeanPharmaceuticalReview
December 20, 2021
In a new survey, 35 percent of healthcare professionals believe that digital transformation would improve pre-clinical and clinical trials.
Pharma industry reports 53 deals worth $9.6 billion in November 2021: GlobalData expresspharma
December 06, 2021
The industry reported 105 venture capital (VC) deals worth $4.2 billion in November 2021, compared to the last 12-month average (November 2020 to October 2021) of 173 deals worth $5.2 billion.
Parkinson’s disease market sales to reach $11.5 billion in 2029 europeanpharmaceuticalreview
August 12, 2021
The Parkinson’s disease market is set to triple in sales by 2029 driven by novel biologics and delivery systems, reports GlobalData.
Pharma industry reports 75 deals worth $26.6 billion in July 2021: GlobalData expresspharma
August 09, 2021
The industry also reported 112 venture capital (VC) deals worth $3.8 billion in the same month.
Pharma cos foray into digital healthcare to bolster personalised care in India: GlobalData expresspharma
August 09, 2021
In the last three years, Abbott, Biocon, Cipla, Dr Reddy's Laboratories and Lupin have launched digital health initiatives.
Private equity firms acquiring top CMOs at a rapid rate: GlobalData expresspharma
July 30, 2021
GlobalData’s report states that PE-backed CMOs will find they have a lot more financial support to add to their service offerings and value.
COVID-19 vaccine market set to reach $19.5bn by 2026 pharmaceutical-technology
July 26, 2021
The size of the COVID-19 vaccine market across the seven major markets – the US, Germany, France, Italy, Spain, the UK, and Japan -will increase from $13.6bn in 2021 to $19.5bn in 2026 at a compound annual growth rate (CAGR) of 7.6% should annual ...
2021 a pivotal year for personalised neoantigens, says GlobalData europeanpharmaceuticalreview
July 22, 2021
With multiple catalysts coming up in late 2021, GlobalData reports a boom in the field of personalised neoantigen immuno-oncology therapeutics.
AI and big data will continue to disrupt pharma sector, says survey europeanpharmaceuticalreview
July 20, 2021
A GlobalData report has revealed the extent to which companies will be using AI and big data in drug discovery and development processes.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page